We are live on ! Find out more
NL

NKCFO LLC Portfolio holdings

AUM $337M
1-Year Est. Return 58.12%
This Fund
S&P 500
This Quarter Est. Return
-0.5%
1 Year Est. Return
+58.12%
3 Year Est. Return
+202.04%
5 Year Est. Return
+251.25%
10 Year Est. Return
AUM
$299M
AUM Growth
+$1.01M
Cap. Flow
+$6.94M
Cap. Flow %
2.32%
Top 10 Hldgs %
63.15%
Holding
119
New
15
Increased
13
Reduced
11
Closed
37

Sector Composition

Rank Sector Weight
1 Materials 15.92%
2 Technology 11.92%
3 Real Estate 10.14%
4 Communication Services 10.04%
5 Consumer Discretionary 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAAS icon
101
Pan American Silver
PAAS
$17.6B
-3,200
Closed -$91K
PINS icon
102
Pinterest
PINS
$13B
-4,700
Closed -$371K
PLBY icon
103
Playboy Inc
PLBY
$135M
-15,800
Closed -$614K
PSQ icon
104
ProShares Short QQQ
PSQ
$657M
-44,000
Closed -$2.73M
ROKU icon
105
Roku
ROKU
$21.4B
-550
Closed -$253K
RVLV icon
106
Revolve Group
RVLV
$1.78B
-11,000
Closed -$758K
TDOC icon
107
Teladoc Health
TDOC
$1.7B
-1,300
Closed -$216K
TTD icon
108
Trade Desk
TTD
$8.74B
-7,300
Closed -$565K
ULTA icon
109
Ulta Beauty
ULTA
$20.6B
-600
Closed -$207K
URBN icon
110
Urban Outfitters
URBN
$6.25B
-21,500
Closed -$886K
ZYXI
111
DELISTED
Zynex
ZYXI
-15,400
Closed -$217K
BNT
112
Brookfield Wealth Solutions
BNT
$11.9B
-234
Closed -$8K
VWE
113
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
-34,000
Closed -$408K
JOAN
114
DELISTED
JOANN, Inc. Common Stock
JOAN
-6,500
Closed -$102K
NVTA
115
DELISTED
Invitae Corporation
NVTA
-19,200
Closed -$648K
FTCH
116
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-4,200
Closed -$212K
TBIO
117
DELISTED
Translate Bio, Inc. Common Stock
TBIO
-6,500
Closed -$179K
HZNP
118
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-2,200
Closed -$206K
ATIP
119
DELISTED
ATI Physical Therapy, Inc.
ATIP
-1,680
Closed -$801K

Similar funds

NKCFO LLC's Q3 2021 Portfolio in Review

As of Q3 2021, NKCFO LLC held 119 positions worth $299M, up 0.34% from $298M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

NKCFO LLC's Q3 2021 filing shows 15 new, 13 increased, 11 reduced and 37 closed positions. Its largest new stake was GSK: 215,600 shares worth $10.3M. The largest sale was Freeport-McMoran, an estimated $4.71M.

By sector, the portfolio is most concentrated in Materials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Real Estate.

  • NKCFO LLC's largest Q3 2021 buy was GSK: 215,600 shares worth $10.3M.
  • NKCFO LLC added most to Pershing Square Tontine Holdings, Ltd. in Q3 2021, an estimated $2.15M increase.
  • NKCFO LLC's biggest Q3 2021 reduction was Vanguard Short-Term Inflation-Protected Securities Index Fund, cutting an estimated $4.14M.
  • NKCFO LLC fully exited Freeport-McMoran in Q3 2021, selling an estimated $4.71M.
  • NKCFO LLC's ten largest holdings make up 63% of its $299M portfolio in Q3 2021.
  • NKCFO LLC opened 15 new positions and closed 37 in Q3 2021.
  • NKCFO LLC's portfolio value rose 0.34% quarter-over-quarter to $299M.

Based on NKCFO LLC's 13F filing for Q3 2021, filed 21 Oct 2021.